Suhre, Karsten http://orcid.org/0000-0001-9638-3912
McCarthy, Mark I. http://orcid.org/0000-0002-4393-0510
Schwenk, Jochen M. http://orcid.org/0000-0001-8141-8449
Article History
Accepted: 14 July 2020
First Online: 28 August 2020
Competing interests
: M.I.M. has served on advisory panels for Pfizer, NovoNordisk and Zoe Global, has received honoraria from Merck, Pfizer, NovoNordisk and Eli Lilly, has stock options in Zoe Global and has received research funding from AbbVie, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Merck, NovoNordisk, Pfizer, Roche, Sanofi Aventis, Servier and Takeda. As of June 2019, M.I.M. is an employee of Genentech and holds stock in Roche. K.S. and J.M.S. declare no competing interests.